IMS Health

Activities: Media

The demand for reliable market intelligence and accountability in global healthcare has never been greater.

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. Overcoming CMC challenges in cell and gene therapy: part II Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
  3. SNIPR Biome receives funding to progress CRISPR medicine SNIPR001 into clinical trials Phase 1b/2a trial will evaluate SNIPR001 for the prevention of E.coli infections in patients undergoing hematopoietic stem cell transplantation
  4. Kindeva Drug Delivery appoints Denis Johnson as Chief Operating Officer Denis will be responsible for optimising global operations for the company
  5. SeaBeLife awarded over €1.5 million in i-Nov innovation competition Funding for company’s SeaBeEYE project will be used to develop a new therapeutic approach for geographic atrophy, a form of age-related macular degeneration

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

Related Content

Media

CPhI Worldwide report forewarns of intense battle between innovators and biogeneric companies

Experts state pharmaceutical regulation will shift due to increased data dependence, warn regulatory oversight is slowing six sigma adoption and forecast increased generic options 2025 onwards
Media

QuintilesIMS and Teva UK win award for harmonised data analytics

This BHBIA “Excellence in Business Analytics” award also includes recognition of the advanced marketing insight programme
You need to be a subscriber to read this article.
Click here to find out more.
Media

New stage set for finished dosage form providers

Susan Birks reports on the addition of Finish Dosage Formulation (FDF) to this year’s CPhI Worldwide event
You need to be a subscriber to read this article.
Click here to find out more.
Media

Flying the flag for quality

CPhI Pharma Insights recently published its report on the US market – produced in collaboration with research partner GBR. It reveals that while the US leads the world in many respects, there are some areas, such as biologics, where it currently lags behind
Media

Price control unlikely to improve access to medicines in India

Price control is neither an effective nor a sustainable strategy for improving access to medicines for Indian patients, says to a new report by the IMS Institute India
You need to be a subscriber to read this article.
Click here to find out more.

Syrian conflict: nobody wins

The war in Syria has not only decimated the country’s healthcare infrastructure, but has also failed to benefit the pharma industry in the neighbouring countries coping with a refugee influx

CPhI Worldwide 2014 points to pharma growth in Brazil, Russia and fast emerging Africa

Biggest ever event with 36,000 global professionals is now the key barometer of future pharma industry health, analysis and forecasting
Subscribe now